A research team at The University of Osaka, joined by Professor Shimon Sakaguchi—the latest Nobel Laureate in Physiology or Medicine—has identified a previously uncharacterized subset of immune cells ...
By analyzing the tumor environment of diffuse large B-cell lymphoma (DLBCL), researchers from The University of Texas MD ...
Metabolism guides the activation states of regulatory T cells, the immune cells that prevent inappropriate activation of the ...
News Medical on MSN
Leveraging the power of T cells for more effective and durable cancer immunotherapies
T cells play central roles in the adaptive immune response against cancer. Their functional inactivation is a primary driver of tumor progression, making the reactivation of T cell function a main ...
Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.
Breakthrough method turns ‘cold’ tumors into immune targets, raising hope for lasting cancer control - Anadolu Ajansı ...
Nobel laureate Shimon Sakaguchi reflects on the role of regulatory T cells in peripheral immune tolerance and how the cells ...
Results from pre-clinical studies demonstrate immunomodulatory activity of QEL-005 across multiple immune cell lineages involved in complex autoimmune inflammation, including B cells, T cells and ...
The latest chemistry news, including important research advances, business and policy trends, chemical safety practices, career guidance, and more. Current approved CAR T-cell therapy treatments rely ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients with systemic lupus erythematosus who received ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results